AU1108192A - A plasmodium falciparum blood-stage antigen, the preparation and use thereof - Google Patents

A plasmodium falciparum blood-stage antigen, the preparation and use thereof

Info

Publication number
AU1108192A
AU1108192A AU11081/92A AU1108192A AU1108192A AU 1108192 A AU1108192 A AU 1108192A AU 11081/92 A AU11081/92 A AU 11081/92A AU 1108192 A AU1108192 A AU 1108192A AU 1108192 A AU1108192 A AU 1108192A
Authority
AU
Australia
Prior art keywords
preparation
plasmodium falciparum
stage antigen
falciparum blood
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU11081/92A
Other versions
AU663068B2 (en
Inventor
Erika Hundt
Bernhard Knapp
Hans Kupper
Dagmar Nolte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Vaccines GmbH
Original Assignee
Chiron Behring GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Behring GmbH and Co KG filed Critical Chiron Behring GmbH and Co KG
Publication of AU1108192A publication Critical patent/AU1108192A/en
Application granted granted Critical
Publication of AU663068B2 publication Critical patent/AU663068B2/en
Assigned to CHIRON BEHRING GMBH & CO. reassignment CHIRON BEHRING GMBH & CO. Alteration of Name(s) in Register under S187 Assignors: BEHRINGWERKE AKTIENGESELLSCHAFT
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU11081/92A 1991-02-21 1992-02-20 A plasmodium falciparum blood-stage antigen, the preparation and use thereof Ceased AU663068B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4105348A DE4105348A1 (en) 1991-02-21 1991-02-21 A PLASMODIUM FALCIPARUM BLOOD STAGE ANTIGUE, ITS PRODUCTION AND USE
DE4105348 1991-02-21

Publications (2)

Publication Number Publication Date
AU1108192A true AU1108192A (en) 1992-08-27
AU663068B2 AU663068B2 (en) 1995-09-28

Family

ID=6425521

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11081/92A Ceased AU663068B2 (en) 1991-02-21 1992-02-20 A plasmodium falciparum blood-stage antigen, the preparation and use thereof

Country Status (15)

Country Link
EP (1) EP0499834B1 (en)
JP (1) JPH06141868A (en)
KR (1) KR920016593A (en)
AR (1) AR245782A1 (en)
AT (1) ATE173015T1 (en)
AU (1) AU663068B2 (en)
CA (1) CA2061575A1 (en)
DE (2) DE4105348A1 (en)
DK (1) DK0499834T3 (en)
ES (1) ES2129030T3 (en)
GR (1) GR3029265T3 (en)
IE (1) IE920541A1 (en)
MX (1) MX9200711A (en)
UY (1) UY23357A1 (en)
ZA (1) ZA921231B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006737A1 (en) * 1993-09-03 1995-03-09 Kenneth Francis Prendergast Glycophorin binding protein (gbp130) fusion compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986004922A1 (en) * 1985-02-20 1986-08-28 Memorial Sloan-Kettering Cancer Center cDNA CODING FOR PLASMODIUM FALCIPARUM GLYCOPHORIN BINDING PROTEINS WEIGHING 130,000 DALTONS AND 155,000 DALTONS

Also Published As

Publication number Publication date
KR920016593A (en) 1992-09-25
AU663068B2 (en) 1995-09-28
UY23357A1 (en) 1992-01-23
EP0499834A3 (en) 1993-02-17
JPH06141868A (en) 1994-05-24
MX9200711A (en) 1992-08-01
DE59209544D1 (en) 1998-12-10
IE920541A1 (en) 1992-08-26
DK0499834T3 (en) 1999-07-19
ATE173015T1 (en) 1998-11-15
DE4105348A1 (en) 1992-09-03
GR3029265T3 (en) 1999-05-28
ES2129030T3 (en) 1999-06-01
ZA921231B (en) 1992-10-28
AR245782A1 (en) 1994-02-28
CA2061575A1 (en) 1992-08-22
EP0499834B1 (en) 1998-11-04
EP0499834A2 (en) 1992-08-26

Similar Documents

Publication Publication Date Title
DE69321914D1 (en) Antibodies against Plasmodium falciparum
ZA922011B (en) Vaccine
SG72629A1 (en) Polymers preparation
AP9100332A0 (en) Vaccines
IL90849A0 (en) Synthetic vaccine against p.falciparum malaria
ZA926189B (en) Beta-Phenylisoserine derivatives and their preparation and use.
AU5293486A (en) Malaria vaccine against plasmodium falciparum
AU6777490A (en) Malaria vaccine
AUPM368994A0 (en) Malaria merozoite antigen subunit vaccine
AU1108192A (en) A plasmodium falciparum blood-stage antigen, the preparation and use thereof
EP0584212A4 (en) Liposomal polysaccharide vaccines.
EP0442086A3 (en) Graftcopolymers, their preparation and their use
AU9125791A (en) Protective four amino acid epitope against plasmodium vivax malaria
AU637468B2 (en) Plasmodium sporozoite antigen
AU8442591A (en) Plasmodium vivax and plasmodium knowlesi duffy receptor
AU5450590A (en) Malaria vaccine
AU3069989A (en) Rhoptry membrane antigen of plasmodium falciparum
AU648422B2 (en) Substituted 1-phenyl-1-benzoylamino-5-aminopentanes, their preparation and use
ZA93236B (en) Babesial rhoptry antigens.
AU5851390A (en) A malaria vaccine
GB9102294D0 (en) Antigen of plasmodium falciparum
GB9101987D0 (en) Adhesives,their preparation and use
GB9104396D0 (en) Compound,preparation and use
AU1571595A (en) Malaria merozoite antigen subunit vaccine
AU624930B2 (en) Pp4-delta, the preparation and use thereof